News about

BioReference Labs buys US Ariosa centralized laboratory prenatal testing business from Roche

BioReference Labs buys US Ariosa centralized laboratory prenatal testing business from Roche

BioReference Laboratories, Inc., an OPKO Health company announced the acquisition of the US Ariosa centralized laboratory prenatal testing business from Roche.

| 18/08/2021 | By 346

Lupin receives US FDA tentative approval for generic Briviact tablets

Lupin receives US FDA tentative approval for generic Briviact tablets

Global pharma major Lupin Limited announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) brivaracetam tablets

| 17/08/2021 | By 181

SCHOTT AG announce JV with Serum Institute of India for pharmaceutical packaging

SCHOTT AG announce JV with Serum Institute of India for pharmaceutical packaging

Germany's specialty glass company SCHOTT AG has announced joint venture with Serum Institute of India, the world's largest vaccine producer and manufacturer of highly-effective biologics for pharmaceutical packaging

| 17/08/2021 | By 455

Test At Home completes clinical trial on 'Lollipop-like' device that uses saliva for Covid-19 testing

Test At Home completes clinical trial on 'Lollipop-like' device that uses saliva for Covid-19 testing

Test At Home (TAH), backed by global VC firm Antler, is a medical technology startup, has completed clinical trial on its proprietary 'Lollipop-like' device that enables individuals to self-collect saliva sample for Covid-19 testing with around 95% accuracy based on initial clinical data

| 17/08/2021 | By 322

Pfizer's Ticovac vaccine gets US FDA approval for active immunization

Pfizer's Ticovac vaccine gets US FDA approval for active immunization

Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved Ticovac (tick-borne encephalitis (TBE) vaccine) for active immunization to prevent TBE in individuals 1 year of age and older

| 16/08/2021 | By 421

NIPGR testing potential molecule against Covid-19

NIPGR testing potential molecule against Covid-19

The New Delhi-based National Institute of Plant Genome Research (NIPGR), an autonomous institution supported by the Department of Biotechnology, is testing the potential activity of identified molecules against Covid-19 in collaboration with the New Delhi-based International Centre for Genetic Engineering and Biotechnology (ICGEB)

| 14/08/2021 | By 230

A 10-day quality control programme for pharma industry professionals by PTI

A 10-day quality control programme for pharma industry professionals by PTI

The Pharmacy Training Institute (PTI) has presented a new dimension in quality control as the ongoing pandemic is now increasing its focus on high quality operations across research and manufacturing. The sector is witnessing a shortfall of 25,000 to 30,000 quality control, quality assurance and manufacturing talent pool

| 13/08/2021 | By 417

Syngene expands biopharma-manufacturing capacity with advanced microbial facility; expands mammalian unit

Syngene expands biopharma-manufacturing capacity with advanced microbial facility; expands mammalian unit

Syngene International, an integrated research, development and cGMP manufacturing services company has set up and commissioned a new microbial cGMP unit. It has also expanded the capacity of its mammalian cell manufacturing facility

| 12/08/2021 | By 348

F&S notes global medical imaging & informatics market thrives with AI and cloud to spur growth

F&S notes global medical imaging & informatics market thrives with AI and cloud to spur growth

Frost & Sullivan has noted that the healthcare sector's emphasis on meeting its Quadruple Aim goal of cost reduction, clinical outcomes, enhance the patient and caregiver experience, and improve the work-life of its medical professionals, nurses and paramedics encourages the medical imaging and informatics industry to use advanced technologies

| 12/08/2021 | By 244

Cipla receives US FDA approval for generic Durezol

Cipla receives US FDA approval for generic Durezol

Cipla Limited has received final approval for its Abbreviated New Drug Application (ANDA) for difluprednate ophthalmic emulsion 0.05% from the United States Food and Drug Administration (FDA)

| 12/08/2021 | By 220

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members